Cardinal Health Return on Tangible Equity 2010-2023 | CAH

Current and historical return on tangible equity values for Cardinal Health (CAH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Cardinal Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $0.64B $-8.82B -7.21%
2023-09-30 $0.16B $-8.92B -1.76%
2023-06-30 $0.26B $-8.93B -2.92%
2023-03-31 $0.46B $-8.79B -5.28%
2022-12-31 $-1.27B $-8.83B 14.54%
2022-09-30 $-1.09B $-9.15B 12.95%
2022-06-30 $-0.93B $-8.34B 11.22%
2022-03-31 $-0.96B $-8.72B 11.50%
2021-12-31 $0.56B $-7.60B -6.75%
2021-09-30 $1.14B $-8.61B -13.19%
2021-06-30 $0.61B $-8.30B -6.87%
2021-03-31 $1.15B $-8.39B -12.53%
2020-12-31 $1.38B $-9.13B -14.34%
2020-09-30 $0.97B $-9.76B -9.75%
2020-06-30 $-3.70B $-9.48B 36.12%
2020-03-31 $-4.16B $-10.17B 45.04%
2019-12-31 $-4.21B $-10.52B 52.03%
2019-09-30 $-4.15B $-10.76B 59.76%
2019-06-30 $1.36B $-5.48B -23.48%
2019-03-31 $0.00B $-5.63B -0.03%
2018-12-31 $-0.04B $-5.93B 0.62%
2018-09-30 $0.73B $-6.18B -11.35%
2018-06-30 $0.26B $-6.17B -3.67%
2018-03-31 $1.70B $-6.76B -28.14%
2017-12-31 $1.82B $-6.75B -36.50%
2017-09-30 $1.09B $-8.23B -27.07%
2017-06-30 $1.29B $-2.38B -47.56%
2017-03-31 $1.35B $-2.62B -47.61%
2016-12-31 $1.35B $-2.94B -48.66%
2016-09-30 $1.35B $-2.90B -51.27%
2016-06-30 $1.43B $-2.86B -65.63%
2016-03-31 $1.39B $-2.42B -99.21%
2015-12-31 $1.37B $-2.39B -192.28%
2015-09-30 $1.33B $-1.04B -2229.29%
2015-06-30 $1.22B $0.24B 429.71%
2015-03-31 $1.15B $0.34B 324.16%
2014-12-31 $1.10B $0.22B 217.86%
2014-09-30 $1.09B $0.33B 154.16%
2014-06-30 $1.17B $0.53B 144.40%
2014-03-31 $0.35B $0.94B 44.77%
2013-12-31 $0.38B $1.03B 58.49%
2013-09-30 $0.40B $0.73B 43.95%
2013-06-30 $0.33B $0.40B 28.00%
2013-03-31 $1.16B $0.42B 74.30%
2012-12-31 $1.14B $2.11B 59.62%
2012-09-30 $1.10B $1.84B 60.91%
2012-06-30 $1.07B $1.85B 62.25%
2012-03-31 $1.04B $1.87B 62.66%
2011-12-31 $0.95B $1.68B 61.87%
2011-09-30 $0.90B $1.47B 64.53%
2011-06-30 $0.96B $1.59B 59.36%
2011-03-31 $0.98B $1.39B 49.60%
2010-12-31 $0.96B $1.14B 39.78%
2010-09-30 $0.98B $2.34B 34.23%
2010-06-30 $0.64B $3.02B 21.90%
2010-03-31 $0.69B $3.10B 18.26%
2009-12-31 $0.78B $2.93B 21.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $25.885B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
Merit Medical Systems (MMSI) United States $4.272B 24.44
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00